| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $60.0M | -6.3% |
| SG&A Expense | $24.1M | -4.3% |
| Operating Income | -$84.1M | +5.7% |
| Pre-tax Income | -$77.8M | +3.3% |
| Income Tax | $0 | — |
| Net Income | -$77.9M | +3.3% |
| EPS (Basic) | -$2.02 | +15.1% |
| EPS (Diluted) | -$2.02 | +15.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.5M | +4.2% |
| Short-term Investments | $77.1M | -44.8% |
| Current Assets | $120.4M | -33.7% |
| Total Assets | $129.7M | -34.0% |
| Current Liabilities | $15.7M | -9.0% |
| Total Liabilities | $17.2M | -13.1% |
| Stockholders' Equity | $112.5M | -36.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$63.7M | +3.1% |
| Capital Expenditures | $1.7M | -39.7% |
| Investing Cash Flow | $66.1M | +227.7% |
| Financing Cash Flow | -$749K | -100.6% |
| Free Cash Flow | -$65.3M | +4.5% |